Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | SOT101 |
Trade Name | |
Synonyms | RL-I15|RLI 15|RLI-15|RLI15|SO C101|SOC101|SOT 101|SOT-101|SO-C101 |
Drug Descriptions |
SOT101 (SO-C101) is a fusion protein comprising IL15 and IL15RA, which may stimulate anti-tumor immune response (J Clin Oncol 40, no. 16_suppl (June 01, 2022) 2502). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C170516 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cetuximab + SOT101 | Cetuximab SOT101 | 0 | 1 |
Pembrolizumab + SOT101 | Pembrolizumab SOT101 | 0 | 2 |
SOT101 | SOT101 | 0 | 1 |